Evidence map›Paper›PMID 31847357›Full record

ArticleBehavioral sciences (Basel, Switzerland)2019

Examining the Convergent Validity of the Triarchic Psychopathy Measure Using a Sample of Incarcerated and on Probation Lithuanian Juveniles.

Laura Ustinavičiūtė, Alfredas Laurinavičius, Virginija Klimukienė, Ilona Laurinaitytė, Mykolas Baltrūnas

Abstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura UstinavičiūtėInstitute of Psychology, Vilnius University, 9/1 Universiteto St., 01513 Vilnius, Lithuania.
Alfredas LaurinavičiusInstitute of Psychology, Vilnius University, 9/1 Universiteto St., 01513 Vilnius, Lithuania.
Virginija KlimukienėInstitute of Psychology, Vilnius University, 9/1 Universiteto St., 01513 Vilnius, Lithuania.
Ilona LaurinaitytėInstitute of Psychology, Vilnius University, 9/1 Universiteto St., 01513 Vilnius, Lithuania.ORCID 0000-0002-6812-8276
Mykolas BaltrūnasInstitute of Psychology, Vilnius University, 9/1 Universiteto St., 01513 Vilnius, Lithuania.

Funding

The Research Council of Lithuania S-MIP-17-112
6 · The paper itself

Abstract

The Triarchic Psychopathy Measure (TriPM) is based on the triarchic psychopathy model proposed by Patrick, Fowles, and Krueger in 2009. This paper assesses the convergent validity of TriPM using a number of measures for a sample of adolescents who are either incarcerated or on probation. These included the Short-Term Assessment of Risk and Treatability: Adolescent Version (START: AV); the Subtypes of Antisocial Behavior Questionnaire (STAB); the Criminal Sentiments Scale-Modified (CSS-M); and the Measure of Criminal Social Identity (MCSI). The results showed significant differences between groups that are incarcerated and those on probation, with the incarcerated sample of juveniles exhibiting higher ratings in terms of Disinhibition and lower ratings for Boldness. The TriPM measures examined also show expected positive correlations with concurrent measures related to criminal behavior in both of the aforementioned samples of juveniles. A different pattern of correlations was observed between Boldness and STAB scales, with a large positive correlation found in the incarcerated sample, while no significant correlations were detected in the probation sample. The results support the usefulness of TriPM in assessing the psychopathy in samples of the juvenile offenders chosen for our research purposes.

Indexed as

convergent validityjuvenilespsychopathyTriPM

Identifiers

PMID31847357
PMCPMC6960913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.